NCT00576368View on ClinicalTrials.gov

An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice

PHASE4CompletedINTERVENTIONAL

Enrollment

4,464

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

April 30, 2004

Conditions

Diabetes Mellitus

Interventions

DRUG

INSULIN GLARGINE

The physician will be guided by the prescribing information outlined in the summary of product characteristics. The administration will be done by once daily subcutaneous injection.

Trial Locations (1)

Unknown

Sanofi-Aventis, Brussels